Hannah Dimmick

Ms. Hannah Dimmick

University of Calgary, Calgary, Alberta, Canada
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 August 2023 in Acta Physiologica
Verified
Journal Article
Closed access
AOAlex A. Olmos
Alex A. Olmos
ASAdam J. Sterczala
Adam J. Sterczala
MPMandy E. Parra
Mandy E. Parra
HDHannah Dimmick
Hannah Dimmick
JMJonathan D. Miller
Jonathan D. Miller
MTMichael Trevino
Michael Trevino

20 January 2022 in Experimental Brain Research
Verified
Journal Article
Closed access
PDF file
MTMichael Trevino
Michael Trevino
HDHannah Dimmick
Hannah Dimmick
MPMandy Elizabeth Parra
Mandy Elizabeth Parra
ASAdam J. Sterczala
Adam J. Sterczala
JMJonathan Daniel Miller
Jonathan Daniel Miller
THTrent J. Herda
Trent J. Herda

21 December 2023 in Frontiers in Sports and Active Living
Verified
Journal Article
Open access
HDHannah Dimmick
Hannah Dimmick
CRCody R. van Rassel
Cody R. van Rassel
MMMartin J. MacInnis
Martin J. MacInnis
RFReed Ferber
Reed Ferber
Running biomechanics are affected by fatiguing or prolonged runs. However, no evidence to date has conclusively linked this effect to running-related injury (RRI) development or performance implications. Previous investigations using subject-specific models in running have demonstrated higher accuracy than group-based models, however, this has been infrequently applied to fatigue. In this study, two experiments were conducted to determine whether subject-specific models outperformed group-based models to classify running biomechanics during non-fatigued and fatigued conditions. In the first experiment, 16 participants performed four treadmill runs at or around the maximal lactate steady state. In the second experiment, nine participants performed five prolonged runs using commercial wearable devices. For each experiment, two segments were extracted from each trial from early and late in the run. For each participant, a random forest model was applied with a leave-one-run-out cross-validation to classify between the early (non-fatigued) and late (fatigued) segments. Additionally, group-based classifiers with a leave-one-subject-out cross validation were constructed. For experiment 1, mean classification accuracies for the single-subject and group-based classifiers were 68.2 ± 8.2% and 57.0 ± 8.9%, respectively. For experiment 2, mean classification accuracies for the single-subject and group-based classifiers were 68.9 ± 17.1% and 61.5 ± 11.7%, respectively. Variable importance rankings were consistent within participants, but these rankings differed from each participant to those of the group. Although the classification accuracies were relatively low, these findings highlight the advantage of subject-specific classifiers to detect changes in running biomechanics with fatigue and indicate the potential of using big data and wearable technology approaches in future research to determine possible connections between biomechanics and RRI.

29 May 2022 in Sensors
Verified
Journal Article
Open access
PDF file
HDHannah Dimmick
Hannah Dimmick
CRCody van Rassel
Cody van Rassel
Martin MacInnisMartin MacInnis
Martin MacInnis
Reed FerberReed Ferber
Reed Ferber
The purpose of this study was to determine if fatigue-related changes in biomechanics derived from an inertial measurement unit (IMU) placed at the center of mass (CoM) are reliable day-to-day. Sixteen runners performed two runs at maximal lactate steady state (MLSS) on a treadmill, one run 5% above MLSS speed, and one run 5% below MLSS speed while wearing a CoM-mounted IMU. Trials were performed to volitional exhaustion or a specified termination time. IMU features were derived from each axis and the resultant. Feature means were calculated for each subject during non-fatigued and fatigued states. Comparisons were performed between the two trials at MLSS and between all four trials. The only significant fatigue state × trial interaction was the 25th percentile of the results when comparing all trials. There were no main effects for trial for either comparison method. There were main effects for fatigue state for most features in both comparison methods. Reliability, measured by an intraclass coefficient (ICC), was good-to-excellent for most features. These results suggest that fatigue-related changes in biomechanics derived from a CoM-mounted IMU are reliable day-to-day when participants ran at or around MLSS and are not significantly affected by slight deviations in speed.

30 October 2024 in Muscle & Nerve
Verified
Journal Article
Open access
HDHannah Dimmick
Hannah Dimmick
GJGordon Jewett
Gordon Jewett
LKLawrence W. Korngut
Lawrence W. Korngut
RFReed Ferber
Reed Ferber
Introduction/Aims: Fluctuating symptoms and fatigue are common issues in myasthenia gravis (MG), but it is unclear if these symptoms are related to physical activity or sleep patterns. This study sought to determine the day‐to‐day relationship between patient‐reported symptoms and physical activity and sleep over 12 weeks.Methods: Sixteen participants with generalized MG wore a wrist‐mounted accelerometer continuously for the study duration and reported their symptoms and fatigue each evening. Cumulative link mixed models were used to analyze whether clinical and demographic characteristics, physical activity, and sleep were related to symptom severity and fatigue over the study period. Three types of models were constructed: a cohort model, a model in which data was scaled to each participant, and individual models.Results: The cohort model indicated that higher disease severity, female sex, more comorbidities, less physical activity, more inactive time, and lower quantity of sleep were significantly associated with increased symptom severity and fatigue (p < .05). However, in the within‐participant scaled model, there were almost no significant associations with physical activity or sleep. In the individual models, some participants showed similar results to the cohort model, but others showed no associations or the opposite response in some variables.Discussion: While physical activity and sleep were associated with self‐reported symptoms and fatigue within this population, this was not necessarily applicable to individuals. This demonstrates the importance of an individualized analysis for determining how physical activity and sleep may impact outcomes in MG, with implications for clinical and self‐management.

1 January 2025 in Cancer Research Communications
Verified
Journal Article
Open access
FVFabian R. Villagomez
Fabian R. Villagomez
JLJulie Lang
Julie Lang
DNDaniel Nuñez
Daniel Nuñez
KBKian Behbakht
Kian Behbakht
HDHannah Dimmick
Hannah Dimmick
BBBenjamin Bitler
Benjamin Bitler
Alterations in the interplay between the nucleus and the cell cycle during cancer development lead to a state of genomic instability, often accompanied by observable morphologic aberrations. Tumor cells can regulate these aberrations to evade cell death, either by preventing or eliminating genomic instability. In epithelial ovarian cancer, overexpression of claudin-4 significantly contributes to therapy resistance through mechanisms associated with genomic instability regulation. However, the molecular mechanisms underlying claudin-4 overexpression in epithelial ovarian cancer remain poorly understood. In this study, we modified claudin-4 expression and employed a unique claudin mimic peptide to investigate claudin-4’s function. Our findings show that claudin-4 supports ovarian cancer cell survival by stabilizing the genome through nuclear and cell-cycle remodeling. Specifically, claudin-4 induced nuclear constriction by excluding lamin B1 and promoting perinuclear F-actin accumulation, thereby altering nuclear structure and dynamics. Similarly, cell-cycle modifications due to claudin-4 overexpression resulted in fewer cells entering the S-phase and reduced genomic instability in tumors. Importantly, disrupting claudin-4’s biological effects using claudin mimic peptide and forskolin increased the efficacy of PARP inhibitor treatment, correlating with alterations in the oxidative stress response. Our data indicate that claudin-4 protects tumor genome integrity by modulating the crosstalk between the nucleus and the cell cycle, leading to resistance to genomic instability formation and the effects of genomic instability–inducing agents. Significance: High-grade serous ovarian carcinoma is marked by chromosomal instability, which can serve to promote disease progression and allow cancer to evade therapeutic insults. The report highlights the role of claudin-4 in regulating genomic instability and proposes a novel therapeutic approach to exploit claudin-4–mediated regulation.